|
US4181803A
(en)
*
|
1973-12-14 |
1980-01-01 |
Eisai Co., Ltd. |
Propiophenone derivatives and preparation thereof
|
|
DE3369315D1
(en)
*
|
1982-10-27 |
1987-02-26 |
Degussa |
Derivatives of 2-amino-3-acylamino-6-benzylamino pyridine with an anti-epileptic activity
|
|
DE3337593A1
(de)
|
1982-10-27 |
1984-05-03 |
Degussa Ag, 6000 Frankfurt |
2-amino-3-acylamino-6-benzylamino-pyridin-derivate mit antiepileptischer wirkung
|
|
ATE46265T1
(de)
*
|
1985-01-23 |
1989-09-15 |
Asta Pharma Ag |
Synergistische kombination von flupirtin und nicht-steroidalen antiphlogistika.
|
|
DE3604575A1
(de)
|
1985-02-23 |
1986-08-28 |
Degussa Ag, 6000 Frankfurt |
Kombination von flupirtin und anticholinergisch wirkenden spasmolytika
|
|
EP0193056B1
(de)
*
|
1985-02-23 |
1989-06-07 |
ASTA Pharma Aktiengesellschaft |
Kombination von Flupirtin und anticholinergisch wirkenden Spasmolytika
|
|
JP2583067B2
(ja)
*
|
1987-08-04 |
1997-02-19 |
住友化学工業株式会社 |
モノアゾ化合物およびそれを用いて疎水性繊維材料を染色または捺染する方法
|
|
GB8800199D0
(en)
*
|
1988-01-06 |
1988-02-10 |
Beecham Group Plc |
Pharmaceutical preparation
|
|
MC2029A1
(fr)
*
|
1988-05-16 |
1990-04-25 |
Asta Pharma Ag |
(n-heterocyclyl)-3 diamino-2,6 pyridines substituees et leurs n-oxydes,preparation de ces composes et leur application comme medicaments
|
|
US5629307A
(en)
*
|
1989-10-20 |
1997-05-13 |
Olney; John W. |
Use of ibogaine in reducing excitotoxic brain damage
|
|
US6004945A
(en)
*
|
1990-05-10 |
1999-12-21 |
Fukunaga; Atsuo F. |
Use of adenosine compounds to relieve pain
|
|
IN172468B
(enExample)
*
|
1990-07-14 |
1993-08-14 |
Asta Medica Ag |
|
|
US5643921A
(en)
*
|
1990-09-26 |
1997-07-01 |
E.R. Squibb & Sons, Inc. |
Cardiopulmonary bypass and organ transplant using a potassium channel activator
|
|
US5234947A
(en)
*
|
1991-11-07 |
1993-08-10 |
New York University |
Potassium channel activating compounds and methods of use thereof
|
|
DE4200259A1
(de)
*
|
1992-01-08 |
1993-07-15 |
Asta Medica Ag |
Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung
|
|
US5262419A
(en)
*
|
1992-06-11 |
1993-11-16 |
E. R. Squibb & Sons, Inc. |
Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
|
|
CA2115792C
(en)
*
|
1993-03-05 |
2005-11-01 |
David J. Mayer |
Method for the treatment of pain
|
|
US5428039A
(en)
*
|
1994-02-20 |
1995-06-27 |
The Center For Innovative Technology |
Method for electively achieving reversible hyperpolarized cardiac arrest
|
|
US5965582A
(en)
*
|
1994-08-03 |
1999-10-12 |
Asta Medica Aktiengesellschaft |
N-benzylindole and benzopyrazole derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunemodulating effect
|
|
DE69434794T2
(de)
*
|
1994-09-22 |
2007-07-12 |
Smith, Richard Alan, La Jolla |
Kombination von dextromethorphan mit quinidine oder quinine sulfat zur behandlung verschiedener refraktärer störungen
|
|
US5679706A
(en)
*
|
1994-09-30 |
1997-10-21 |
Bristol-Myers Squibb Company |
Combination of a potassium channel activator and an antiarrhythmic agent
|
|
WO1996019233A2
(en)
*
|
1994-12-12 |
1996-06-27 |
Omeros Medical Systems, Inc. |
Irrigation solution and method for inhibition of pain, inflammation and spasm
|
|
DE19539861A1
(de)
*
|
1995-10-26 |
1997-04-30 |
Asta Medica Ag |
Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
|
|
DE19701694A1
(de)
*
|
1997-01-20 |
1998-07-23 |
Asta Medica Ag |
Neue Modifikationen des 2-Amino-4-(4-fluorbenzylamino)-l-ethoxycarbonyl-aminobenzen sowie Verfahren zu ihrer Herstellung
|
|
IN188411B
(enExample)
*
|
1997-03-27 |
2002-09-21 |
Yuhan Corp |
|
|
US5760007A
(en)
*
|
1997-07-16 |
1998-06-02 |
Ortho Pharmaceutical Corporation |
Anticonvulsant derivatives useful in treating neuropathic pain
|
|
ATE308342T1
(de)
*
|
1997-08-08 |
2005-11-15 |
Chugai Pharmaceutical Co Ltd |
Arzneimittel gegen diabetes-komplikationen
|
|
US6265417B1
(en)
*
|
1997-12-18 |
2001-07-24 |
Abbott Laboratories |
Potassium channel openers
|
|
US6593335B1
(en)
*
|
1997-12-18 |
2003-07-15 |
Abbott Laboratories |
Potassium channel openers
|
|
US6211171B1
(en)
*
|
1998-05-19 |
2001-04-03 |
Dalhousie University |
Use of antidepressants for local analgesia
|
|
JP3441970B2
(ja)
|
1998-06-30 |
2003-09-02 |
株式会社サミー |
豆腐の製造方法及び製造装置
|
|
JP2000143510A
(ja)
|
1998-11-16 |
2000-05-23 |
Taisho Pharmaceut Co Ltd |
外用組成物
|
|
EP1143956A3
(en)
*
|
1998-12-14 |
2001-12-12 |
Cellegy Pharmaceuticals, Inc |
Compositions and methods for the treatment of anorectal disorders
|
|
US6281211B1
(en)
*
|
1999-02-04 |
2001-08-28 |
Euro-Celtique S.A. |
Substituted semicarbazides and the use thereof
|
|
GB9903476D0
(en)
*
|
1999-02-17 |
1999-04-07 |
Zeneca Ltd |
Therapeutic agents
|
|
US6451857B1
(en)
*
|
1999-03-10 |
2002-09-17 |
Warner-Lambert Company |
Analgesic compositions comprising anti-epileptic compounds and methods of using same
|
|
US6436923B1
(en)
|
1999-03-17 |
2002-08-20 |
Signal Pharmaceuticals, Inc. |
Compounds and methods for modulation of estrogen receptors
|
|
AT409083B
(de)
*
|
1999-04-01 |
2002-05-27 |
Sanochemia Pharmazeutika Ag |
Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
|
|
US6610324B2
(en)
|
1999-04-07 |
2003-08-26 |
The Mclean Hospital Corporation |
Flupirtine in the treatment of fibromyalgia and related conditions
|
|
GB9915414D0
(en)
|
1999-07-01 |
1999-09-01 |
Glaxo Group Ltd |
Medical use
|
|
HK1047036A1
(zh)
|
1999-07-06 |
2003-02-07 |
Eli Lilly And Company |
用於治疗偏头痛的选择性iglur5，受体拮抗剂
|
|
US6472165B1
(en)
|
1999-08-03 |
2002-10-29 |
Arzneimittelwerk Dresden Gmbh |
Modulatory binding site in potassium channels for screening and finding new active ingredients
|
|
ATE380176T1
(de)
*
|
1999-08-04 |
2007-12-15 |
Icagen Inc |
Benzanilide als öffner des kaliumkanals
|
|
EP1200086A4
(en)
*
|
1999-08-04 |
2009-05-27 |
Icagen Inc |
THERAPEUTIC OR PROPHYLACTIC METHODS OF PAIN AND ANXIETY
|
|
US6495550B2
(en)
*
|
1999-08-04 |
2002-12-17 |
Icagen, Inc. |
Pyridine-substituted benzanilides as potassium ion channel openers
|
|
US6117900A
(en)
*
|
1999-09-27 |
2000-09-12 |
Asta Medica Aktiengesellschaft |
Use of retigabine for the treatment of neuropathic pain
|
|
US6383511B1
(en)
*
|
1999-10-25 |
2002-05-07 |
Epicept Corporation |
Local prevention or amelioration of pain from surgically closed wounds
|
|
US6538004B2
(en)
*
|
2000-03-03 |
2003-03-25 |
Abbott Laboratories |
Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
|
|
US20020015730A1
(en)
*
|
2000-03-09 |
2002-02-07 |
Torsten Hoffmann |
Pharmaceutical formulations and method for making
|
|
US6348486B1
(en)
*
|
2000-10-17 |
2002-02-19 |
American Home Products Corporation |
Methods for modulating bladder function
|
|
US6589986B2
(en)
*
|
2000-12-20 |
2003-07-08 |
Wyeth |
Methods of treating anxiety disorders
|
|
AU2002256995A1
(en)
*
|
2001-02-07 |
2002-08-28 |
Ortho-Mcneil Pharmaceutical, Inc. |
Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
|
|
US6469042B1
(en)
*
|
2001-02-20 |
2002-10-22 |
Bristol-Myers Squibb Company |
Fluoro oxindole derivatives as modulators if KCNQ potassium channels
|
|
AU2002338333A1
(en)
|
2001-04-04 |
2002-10-21 |
Wyeth |
Methods for treating hyperactive gastric motility
|
|
GB0121214D0
(en)
|
2001-08-31 |
2001-10-24 |
Btg Int Ltd |
Synthetic method
|
|
US6831087B2
(en)
*
|
2001-11-09 |
2004-12-14 |
Hoffmann-La Roche Inc. |
Pyridine substituted isoquinoline derivatives
|
|
MXPA04007590A
(es)
*
|
2002-02-05 |
2004-12-06 |
Yamanouchi Pharma Co Ltd |
Derivado de 2,4,6-triamino-1,3,5-triacina.
|
|
AU2003202115A1
(en)
|
2002-02-12 |
2003-09-04 |
Pfizer Inc. |
Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh)
|
|
ATE533743T1
(de)
|
2002-05-17 |
2011-12-15 |
Janssen Pharmaceutica Nv |
Harnstoffderivate von aminotetralin als modulatoren des vanilloid-rezeptors vr1
|
|
WO2003106454A1
(en)
|
2002-06-12 |
2003-12-24 |
Orchid Chemicals & Pharmaceuticals Ltd |
1h-isoquinoline-oxazolidinone derivaties and their use as antibacterial agents
|
|
AUPS312602A0
(en)
*
|
2002-06-21 |
2002-07-18 |
James Cook University |
Organ arrest, protection, preservation and recovery
|
|
US7419981B2
(en)
*
|
2002-08-15 |
2008-09-02 |
Pfizer Inc. |
Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
|
|
US7045551B2
(en)
*
|
2002-11-22 |
2006-05-16 |
Bristol-Myers Squibb Company |
1-aryl-2-hydroxyethyl amides as potassium channel openers
|
|
ATE488231T1
(de)
*
|
2002-12-23 |
2010-12-15 |
Icagen Inc |
Quinazolinone als kaliumkanalmodulatoren
|
|
CA2511502A1
(en)
|
2002-12-27 |
2004-07-15 |
H. Lundbeck A/S |
1,2,4-triaminobenzene derivatives,useful for treating disorders of the central nervous system
|
|
JP2006520333A
(ja)
|
2003-03-14 |
2006-09-07 |
ハー・ルンドベック・アクチエゼルスカベット |
置換されたアニリン誘導体
|
|
CA2519582A1
(en)
|
2003-03-21 |
2004-09-30 |
H. Lundbeck A/S |
Substituted p-diaminobenzene derivatives
|
|
AU2004233941A1
(en)
|
2003-04-25 |
2004-11-11 |
H. Lundbeck A/S |
Sustituted indoline and indole derivatives
|
|
MXPA05012463A
(es)
|
2003-05-27 |
2006-01-30 |
Altana Pharma Ag |
Combinaciones farmaceuticas de un inhibidor de bomba protonica y un compuesto que modifica la motilidad gastrointestinal.
|
|
US7276608B2
(en)
*
|
2003-07-11 |
2007-10-02 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
|
|
US20050089473A1
(en)
*
|
2003-09-10 |
2005-04-28 |
Cedars-Sinai Medical Center |
Potassium channel mediated delivery of agents through the blood-brain barrier
|
|
US7799832B2
(en)
*
|
2003-10-23 |
2010-09-21 |
Valeant Pharmaceuticals North America |
Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
|
|
DE10359335A1
(de)
|
2003-10-23 |
2005-05-25 |
Viatris Gmbh & Co. Kg |
Kombinationen aus Kaliumkanalöffnern und Natriumkanalinhibitoren oder Natriumkanal beeinflussenden Wirkstoffen zur Behandlung von Schmerzzuständen
|
|
ES2235626B1
(es)
|
2003-11-10 |
2006-11-01 |
Almirall Prodesfarma, S.A. |
Formas de administracion masticables, no comprimidas dosificadas individualmente.
|
|
TW200530235A
(en)
*
|
2003-12-24 |
2005-09-16 |
Renovis Inc |
Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
|
|
TWI357901B
(en)
|
2004-03-12 |
2012-02-11 |
Lundbeck & Co As H |
Substituted morpholine and thiomorpholine derivati
|
|
JP2007532676A
(ja)
|
2004-04-13 |
2007-11-15 |
イカジェン インコーポレイテッド |
カリウムイオンチャネル調節剤としての多環式ピリジン
|
|
CN1968692A
(zh)
*
|
2004-05-03 |
2007-05-23 |
杜克大学 |
影响体重减轻的组合物
|
|
RU2392278C2
(ru)
*
|
2004-07-15 |
2010-06-20 |
Джапан Тобакко Инк. |
Конденсированное производное бензамида и ингибитор активности подтипа 1 рецептора ваниллоида (vr1)
|
|
UA89503C2
(uk)
|
2004-09-13 |
2010-02-10 |
Х. Луннбек А/С |
Заміщені похідні аніліну
|
|
JP2008513508A
(ja)
*
|
2004-09-21 |
2008-05-01 |
シンタ ファーマシューティカルズ コーポレーション |
炎症及び免疫に関連する用途に用いる化合物
|
|
EP1813285A4
(en)
|
2004-11-19 |
2010-06-09 |
Kissei Pharmaceutical |
PROPHYLACTIC OR THERAPEUTIC AGENT AGAINST NEUROPATHIC PAIN
|
|
EP1688141A1
(en)
*
|
2005-01-31 |
2006-08-09 |
elbion AG |
The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
|
|
WO2006092143A1
(en)
|
2005-03-03 |
2006-09-08 |
H. Lundbeck A/S |
Substituted pyridine derivatives
|
|
US7683058B2
(en)
*
|
2005-09-09 |
2010-03-23 |
H. Lundbeck A/S |
Substituted pyrimidine derivatives
|
|
WO2007050348A2
(en)
*
|
2005-10-21 |
2007-05-03 |
Merck & Co., Inc. |
Potassium channel inhibitors
|
|
KR20090079191A
(ko)
|
2006-08-23 |
2009-07-21 |
밸리언트 파마슈티컬즈 인터내셔널 |
칼륨 채널 조절제로서 ４-(ｎ-아자사이클로알킬) 아닐리드의 유도체
|
|
US8030518B2
(en)
|
2006-11-28 |
2011-10-04 |
Valeant Pharmaceuticals International |
1,4 diamino bicyclic retigabine analogues as potassium channel modulators
|
|
US8563566B2
(en)
*
|
2007-08-01 |
2013-10-22 |
Valeant Pharmaceuticals International |
Naphthyridine derivatives as potassium channel modulators
|
|
EP2445340B1
(en)
*
|
2009-06-22 |
2016-05-18 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|